Found 163 clinical trials
EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study) (PALABA)
The main objective of this trial is to test the hypothesis that abatacept can reduce the progression of rheumatoid arthritis in ACPA+ or RF+ patients with palindromic rheumatism compared with
- 0 views
- 19 Apr, 2022
- 1 location
Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor
Phase 2 study of the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of KPL-404 in subjects with moderate to severe Rheumatoid Arthritis.
- 0 views
- 22 Apr, 2022
- 9 locations
Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes (STOP)
Ankylosing spondylitis (AS) is a frequent chronic inflammatory rheumatic disease that affects the axial skeleton, starting in the sacroiliac joints and spreading to the spine in most patients
- 236 views
- 24 Mar, 2022
- 16 locations
Impact of a Gluten-free Diet on Quality of Life in Patients With Axial Spondyloarthritis.
with inflammatory rheumatism who are on gluten-free diets (GFDs), despite the lack of reliable data from controlled studies. This study aims to determine the impact of a GFD on the quality of life of
- 0 views
- 09 Jan, 2022
- 1 location
Methotrexate in Patients With Early Rheumatoid Arthritis (MTXRA)
Rheumatology Quality Register (SRQ) is a nationwide quality register with the aim of continuously improving the treatment and follow-up of patients with rheumatic disease. Using this type of quality registers
- 0 views
- 04 Oct, 2022
- 3 locations
Splenic Stimulation for RA
biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) or JAK inhibitors (JAKis). A sufficient number of participants will be enrolled so that approximately 28 participants will undergo device
- 8 views
- 31 Oct, 2021
- 4 locations
Physiotherapy of Axial Spondyloarthritis
investigators will first recruit up to 300 axSpA patients receiving care at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath into a cohort and observe their standard of care outcomes. This
- 0 views
- 10 Oct, 2021
- 2 locations
The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis
rheumatic drugs are ineffective in the treatment of RA. The addition of tofacitinib to patients may be beneficial to the treatment.
- 8 views
- 22 Jun, 2021
- 1 location
Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis (TOLERANT)
anti-rheumatic drugs (DMARD) will be included. Any combination and dose of DMARD is allowed, with exception of Janus kinase inhibitors. Concomitant use of a low dose of prednisone (7.5 mg per day or
- 0 views
- 10 Mar, 2022
- 1 location
Combination of Baricitinib and Adalimumab in Rheumatoid Arthritis (CRI-RA)
As stated by the European League Against Rheumatism (EULAR) and the Société Française de Rhumatologie (SFR), treatment of patients with rheumatoid arthritis (RA) should target sustained
- 0 views
- 15 Mar, 2022
- 6 locations